Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Pappas

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|April 6, 2023
Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris<i>:</i> Results from a Phase 2 TrialJose A Vazquez, Peter G Pappas, Kenneth Boffard, et al.
Open Forum Infectious Diseases|August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Clinical Epidemiology|September 2, 2024
Epidemiology of Invasive CandidiasisDerek J Bays, Emily N Jenkins, Meghan Lyman, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2019
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasisAndrej Spec, John Pullman, George R Thompson, et al.
Infection Control and Hospital Epidemiology|June 7, 2012
Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usageJames A McKinnell, Danielle F Kunz, Eric Chamot, et al.
BMC Infectious Diseases|February 25, 2014
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trialJose Vazquez, Annette C Reboli, Peter G Pappas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2012
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trialsDavid R Andes, Nasia Safdar, John W Baddley, et al.
International Journal of Antimicrobial Agents|July 3, 2009
Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitisWeerawat Manosuthi, Somnuek Sungkanuparph, Thanomsak Anekthananon, et al.
Medical Mycology|May 15, 2020
Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agendaPeter G Pappas, David R Boulware, Dimitrios P Kontoyiannis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen TestingP Lewis White, John R Wingard, Stéphane Bretagne, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|April 6, 2023
Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris<i>:</i> Results from a Phase 2 TrialJose A Vazquez, Peter G Pappas, Kenneth Boffard, et al.
Open Forum Infectious Diseases|August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Clinical Epidemiology|September 2, 2024
Epidemiology of Invasive CandidiasisDerek J Bays, Emily N Jenkins, Meghan Lyman, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2019
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasisAndrej Spec, John Pullman, George R Thompson, et al.
Infection Control and Hospital Epidemiology|June 7, 2012
Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usageJames A McKinnell, Danielle F Kunz, Eric Chamot, et al.
BMC Infectious Diseases|February 25, 2014
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trialJose Vazquez, Annette C Reboli, Peter G Pappas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2012
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trialsDavid R Andes, Nasia Safdar, John W Baddley, et al.
International Journal of Antimicrobial Agents|July 3, 2009
Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitisWeerawat Manosuthi, Somnuek Sungkanuparph, Thanomsak Anekthananon, et al.
Medical Mycology|May 15, 2020
Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agendaPeter G Pappas, David R Boulware, Dimitrios P Kontoyiannis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2015
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen TestingP Lewis White, John R Wingard, Stéphane Bretagne, et al.
Pageof 18